The JUMPSTART Program: Encouraging Early Mobilization and Optimizing Recovery of TAVR Patients' Post-hospital Discharge
- Disease/Condition
- Aortic Valve Stenosis,Transcatheter Aortic Valve Replacement
- Drug/Device/Intervention
- JUMPSTART exercise program
- Study type
- Observational
- Intervention type
- behavioral
- Primary sponsor
- Hamilton Health Sciences Corporation
- Funder
- McMaster University
- Location
- Hamilton, Canada
- Phase
- N/A
- Start date
- Mar 01, 2023
- End date
- Mar 31, 2024
- Enrollment
- 150 participants
Effectiveness (quality of life),Adoption,Adoption
A virtual, self-directed, and tailored early mobilization program called JUMPSTART, that aims
 to bridge cardiac rehabilitation intake for post-TAVR patients has been developed at the
 Hamilton General Hospital. The program includes a series of exercise videos at varying levels
 of intensity, designed for patients to follow at home, post-discharge. JUMPSTART is currently
 being offered as part of clinical care. In this new pilot study, the study team plans to
 develop and test new strategies to optimize recruitment and participation, develop additional
 JUMPSTART materials and evaluate outcomes through follow-up surveys and
 registry/administrative data at Hamilton General Hospital.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06040398
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06040398 through Pure Global AI's free database. This phase not specified trial is sponsored by Hamilton Health Sciences Corporation and is currently Recruiting. The study focuses on Aortic Valve Stenosis,Transcatheter Aortic Valve Replacement. Target enrollment is 150 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.